Litigation

Merck KGaA v. Hopewell Pharma Ventures, Inc.

judgment

1:22-cv-01365

Auto-generating section 1 of 4: Case overview & background

Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.

Filed
2022-10
Terminated
2026-01-29

Patents at issue (1)

Plaintiffs (1)

Summary

The Delaware District Court entered final judgment in favor of Hopewell Pharma Ventures, Inc., invalidating claims of US8377903 (among other patents) as obvious.

Case overview & background

Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Key legal developments & outcome

Major rulings, motions, claim construction, settlements, and the present posture or final disposition.

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Plaintiff representatives

Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Defendant representatives

Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).